RaySearch's CEO Sells Shares - Remains a Long-term Shareholder
RaySearch's CEO Sells Shares - Remains a Long-term Shareholder
STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- RaySearch's founder and CEO, Johan Löf, has sold 150,000 Class B shares in RaySearch Laboratories AB (publ) on September 24, 2024. Johan Löf remains a long-term shareholder and after the transaction owns 5,443,084 Class A shares and 68,393 Class B shares, corresponding to 16.1 percent of the total number of shares and 52.8 percent of the total number of votes in the company.
2024年9月27日，瑞德尚（RaySearch）的創始人兼首席執行官Johan Löf於2024年9月24日出售了瑞德尚實驗室Ab股份公司（publ）的15萬B類股份。Johan Löf仍然是一位長期股東，在交易後擁有5,443,084個A類股份和68,393個B類股份，相當於公司總股份的16.1％和總投票權的52.8％。
Johan Löf, founder and CEO, RaySearch: "The sale is due to private financial reasons. I remain committed to the company with continued strong confidence in RaySearch's future. We are well positioned for continued growth, and I look forward to continuing to lead and develop RaySearch towards our strategic goals."
瑞德尚的創始人兼首席執行官Johan Löf表示：「出售是出於私人財務原因。我對瑞德尚的未來始終充滿信心。我們已經爲持續增長做好了充分準備，我期待繼續領導和發展瑞德尚實現我們的戰略目標。」
The transaction has been reported to the Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.
根據現行法規，此交易已向瑞典金融監管局（Finansinspektionen）報告。
ABOUT RAYSEARCH
關於 RAYSEARCH
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation* treatment planning system (TPS) and the oncology information system (OIS) RayCare*. The most recent additions to the RaySearch product line are RayIntelligence and RayCommand*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch Laboratories AB 是一家醫療技術公司，致力於開發創新軟件解決方案，用於改善癌症治療。RaySearch 推出了 RayStation* 治療計劃系統（TPS）和腫瘤信息系統（OIS）RayCare*。RaySearch 產品線的最新增加是 RayIntelligence 和 RayCommand*。RayIntelligence 是一款腫瘤學分析系統（OAS），可讓癌症診所收集、整理和分析數據。RayCommand 是一種治療控制系統（TCS），旨在連接治療設備、治療計劃和腫瘤信息系統。
RaySearch's software has been sold to over 1,000 clinics in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
RaySearch 的軟件已銷售給43個國家的1000多家診所。該公司成立於2000年，是斯德哥爾摩卡羅琳斯卡學院的一個分支機構，自2003年起在納斯達克斯德哥爾摩上市。更多信息請訪問 raysearchlabs.com。
* Subject to regulatory clearance in some markets.
* 在一些市場上需要獲得監管批准。
FOR MORE INFORMATION, PLEASE CONTACT:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
欲獲得更多信息，請聯繫:
Johan Löf，RaySearch Laboratories Ab（publ）創始人兼首席執行官
電話：+46 (0) 8 510 530 00
[email protected]
Learn more about us on:
LinkedIn
YouTube
X
了解更多關於我們的信息：
LinkedIn
YouTube
X
This information was brought to you by Cision .
BORR鑽探有限公司來源。
The following files are available for download:
以下文件可供下載：
|
RaySearch Press Release, September 27, 2024_ |
|
RaySearch新聞發佈，2024年9月27日_ |
SOURCE RaySearch Laboratories
來源： RaySearch Laboratories
